Atlanta, Georgia

Atlanta, Georgia 30339

2 studies enrolling now · 7 studies all time

What they study most

Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2, Neurotrophic Keratopathy, Panic Disorder, Schizophrenia

Studies at this site

• A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — Recruiting now
• A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — Recruiting now
• A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder — Stopped early
• A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia — Completed
• A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia — Completed
• A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia — Completed
• Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy — Completed